DGHI Welcomes 3 New Affiliates

Royal, Tomaras, Weinberg

Published March 25, 2014, last updated on April 9, 2018 under Education News

DGHI wouldn’t be what it is today without our world-class faculty. Our faculty are teachers and mentors to a growing cadre of global health students, and they conduct important research around the world to discover evidence and find solutions to a host of global health challenges.  Today, we welcome three new affiliates to DGHI, who work with us on one or more research or education initiatives.

Charmaine Royal, Associate Professor of African & African American Studies and Genome Sciences & Policy
Royal's research and teaching focus on ethical, psychosocial, and societal issues in genetics and genomics, primarily issues at the intersection of genetics/genomics and concepts of ancestry, ethnicity and race. Recent studies have focused on cancer genomics, the decision-making of African patients to terminate pregnancy if affected by sickle cell disease, and perspectives of students and professors on personal DNA testing in the classroom. She serves on several national and international committees and boards.

Georgia Tomaras, Associate Professor of Surgery and Immunology
Tomaras focuses her research on understanding the cellular and humoral immune response to HIV infection and vaccination. She explores antiviral CD8 T cell responses in HIV-1 infection and post vaccination, antibody responses to infection and vaccination in both humans and primates, and the development of neutralizing antibodies. Her laboratory is housed within the Duke Human Vaccine Institute.             

Brice Weinberg, Professor of Medicine and Immunology, Associate Professor of Obstetrics & Gynecology
Weinberg is a hematologist and medical oncologist at the Duke University Medical Center who also serves as staff physician in hematology-oncology at the Durham VA Medical Center. His clinical interests are in hematology and oncology, and his research focuses on blood cells, nitric oxide and leukemia. His current work includes studies on chronic lymphocytic leukemia, resistance to malaria, and inflammation and arthritis.